Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

Novel iboga alkaloid congeners block nicotinic receptors and reduce drug self-administration.

Pace CJ, Glick SD, Maisonneuve IM, He LW, Jokiel PA, Kuehne ME, Fleck MW.

Eur J Pharmacol. 2004 May 25;492(2-3):159-67.

PMID:
15178360
2.

Iboga interactions with psychomotor stimulants: panacea in the paradox?

Szumlinski KK, Maisonneuve IM, Glick SD.

Toxicon. 2001 Jan;39(1):75-86. Review.

PMID:
10936624
3.

Mechanisms of antiaddictive actions of ibogaine.

Glick SD, Maisonneuve IS.

Ann N Y Acad Sci. 1998 May 30;844:214-26. Review.

PMID:
9668680
4.

Drug discrimination studies with ibogaine.

Helsley S, Rabin RA, Winter JC.

Alkaloids Chem Biol. 2001;56:63-77. Review.

PMID:
11705117
5.

Mechanisms of action of ibogaine: relevance to putative therapeutic effects and development of a safer iboga alkaloid congener.

Glick SD, Maisonneuve IM, Szumlinski KK.

Alkaloids Chem Biol. 2001;56:39-53. Review. No abstract available.

PMID:
11705115
6.

The Iboga Alkaloids.

Lavaud C, Massiot G.

Prog Chem Org Nat Prod. 2017;105:89-136. doi: 10.1007/978-3-319-49712-9_2. Review.

PMID:
28194562

Supplemental Content

Support Center